Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company, announced that CEO Paul Bolno will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The pre-recorded presentation will be available for on-demand viewing starting September 13, 2021, at 7:00 a.m. ET. Interested viewers can access the webcast on the company's Investor Relations page and it will be archived for 90 days post-event. Wave Life Sciences focuses on developing innovative treatments for genetically defined diseases using its proprietary PRISM platform.

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to give a pre-recorded presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, which will be made available for on-demand viewing on Monday, September 13, 2021 at 7:00 a.m. ET.

A webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences 
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com 

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com 

FAQ

When will Wave Life Sciences CEO Paul Bolno present at the H.C. Wainwright conference?

Paul Bolno will present on September 13, 2021, at 7:00 a.m. ET.

Where can I watch the Wave Life Sciences presentation?

The presentation can be watched on the Investor Relations page of Wave Life Sciences' corporate website.

How long will the Wave Life Sciences presentation be available for replay?

The replay of the presentation will be available for 90 days following the event.

What is the focus of Wave Life Sciences as a company?

Wave Life Sciences is focused on developing life-changing treatments for genetically defined diseases.

What technology does Wave Life Sciences use for drug development?

Wave Life Sciences utilizes its proprietary PRISM platform for drug discovery and development.